Positrigo
2 known investors
Positrigo develops NeuroLF, an ultra-compact brain Positron Emission Tomography (PET) device for functional brain imaging at a lower cost than conventional systems. The technology targets the diagnosis of brain-related disorders, starting with dementia and Alzheimer's disease.
Investors · 2
Frequently asked questions
- What does Positrigo do?
- Positrigo develops NeuroLF, an ultra-compact brain Positron Emission Tomography (PET) device for functional brain imaging at a lower cost than conventional systems. The technology targets the diagnosis of brain-related disorders, starting with dementia and Alzheimer's disease.
- Who are Positrigo's investors?
- Positrigo's investors include HealthCap, kineo finance.